Patients with muscle disorders can present a diagnostic challenge to physicians because of the different ways they can present and the large number of different underlying causes. Recognition of the 'myopathic phenotype' coupled with investigations usually including electrodiagnostic and histological investigations have been essential for diagnosing the underlying cause of a myopathy. Despite these standard investigations, some patients can remain undiagnosed. New tests including more specific antibody tests for immune-mediated myopathies and the introduction of next-generation sequencing promise to revolutionise diagnostic approaches for immune and inherited myopathies, but clinical expertise remains essential to choose the most appropriat...
Objective Currently, neurologists may primarily rely on blood biomarkers, muscle biopsy, MRI, and ge...
Diseases of muscle may be congenital or acquired. They cause muscle weakness without sensory loss. T...
BACKGROUND: Early-onset myopathies are a heterogeneous group of neuromuscular diseases with broad cl...
Neuromuscular Disorder SymposiumDiagnosing a neuromuscular disorder is a multi-step process and ofte...
Primary muscle disorders (myopathies) are rare, even within a neurology clinic. It has been estimate...
Various pathological processes, some genetically determined and others acquired, may affect the func...
The inherited myopathies and muscular dystrophies are a diverse group of muscle diseases presenting ...
Interest in muscle MRI has been largely stimulated in the last few years by the recognition of an in...
Background: Neuromuscular disorders are rare, inherited progressive disorders leading to major disab...
Purpose of review The development of next-generation sequencing (NGS) technologies is transforming t...
Abstract Objective Muscle biopsy is a part of paraclinical workup of patients with neuromuscular di...
AbstractOver the past decade there have been major advances in defining the genetic basis of the maj...
Muscle diseases or myopathies have heterogeneous clinical presentations and etiologies. The principa...
Myopathies are rare diseases. They may be genetic (muscular dystrophies, metabolic or congenital myo...
International audienceWeakness is one of the predominant clinical manifestations of neuromuscular di...
Objective Currently, neurologists may primarily rely on blood biomarkers, muscle biopsy, MRI, and ge...
Diseases of muscle may be congenital or acquired. They cause muscle weakness without sensory loss. T...
BACKGROUND: Early-onset myopathies are a heterogeneous group of neuromuscular diseases with broad cl...
Neuromuscular Disorder SymposiumDiagnosing a neuromuscular disorder is a multi-step process and ofte...
Primary muscle disorders (myopathies) are rare, even within a neurology clinic. It has been estimate...
Various pathological processes, some genetically determined and others acquired, may affect the func...
The inherited myopathies and muscular dystrophies are a diverse group of muscle diseases presenting ...
Interest in muscle MRI has been largely stimulated in the last few years by the recognition of an in...
Background: Neuromuscular disorders are rare, inherited progressive disorders leading to major disab...
Purpose of review The development of next-generation sequencing (NGS) technologies is transforming t...
Abstract Objective Muscle biopsy is a part of paraclinical workup of patients with neuromuscular di...
AbstractOver the past decade there have been major advances in defining the genetic basis of the maj...
Muscle diseases or myopathies have heterogeneous clinical presentations and etiologies. The principa...
Myopathies are rare diseases. They may be genetic (muscular dystrophies, metabolic or congenital myo...
International audienceWeakness is one of the predominant clinical manifestations of neuromuscular di...
Objective Currently, neurologists may primarily rely on blood biomarkers, muscle biopsy, MRI, and ge...
Diseases of muscle may be congenital or acquired. They cause muscle weakness without sensory loss. T...
BACKGROUND: Early-onset myopathies are a heterogeneous group of neuromuscular diseases with broad cl...